
    
      This study is a randomized controlled trial and held in Cipto Mangunkusumo Hospital.

      Pregnant women 28-34 weeks of gestational age, who fulfill the inclusion criteria, divide
      into two groups. Subjects from both groups receive the hospital protocol of preterm birth, 4
      doses of 6 mg of dexamethasone, intravenous 12 hours apart to support lung maturation.
      Subjects in intervention group receive oral single-dose beta-carotene 25,000 IU, oral
      single-dose vitamin D3 50,000 IU and oral zinc 50 mg/day for 3 days. The maternal dan cord
      blood sample are obtained for zinc, vitamin A and 25(OH)D levels before and after
      intervention. After the premature neonates was born, observation will be done for maximum
      period of 4 weeks. The presence and severity of HMD and feeding intolerance or NEC will be
      recorded. Neonates showing any signs of HMD and/or abdominal distension will need to undergo
      additional chest/abdominal x-ray procedures.
    
  